See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 15, 2010

Anti-Nicotine Vaccine (Smoking Cessation) Depression Cancer-Related Pain

(HealthDay News) -- Here are the latest clinical trials, courtesy of

Anti-Nicotine Vaccine (Smoking Cessation)

This study will evaluate how an anti-nicotine vaccine. It's designed to produce antibodies that absorb nicotine in your blood, reducing nicotine levels in your brain and helping you to quit smoking.

The research site is in Winston-Salem, N.C.

More information

Please see



This study will evaluate an investigational drug as an add-on treatment to an approved antidepressant. Candidates must be aged 18 to 65 and diagnosed with major depressive disorder.

The research site is in Atlanta, Ga.

More information

Please see


Cancer-Related Pain

This study seeks people with cancer-related pain. If you qualify, you may receive study-related medical evaluations at no cost, and compensation for time and travel.

The research site is in Laguna Hills, Calif.

More information

Please see


Copyright 2010 All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.